Skip to content

Frailty Screening in the Swedish Emergency Department Setting

Frailty Screening in the Swedish Emergency Department Setting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04877028
Enrollment
1800
Registered
2021-05-07
Start date
2021-05-17
Completion date
2021-11-14
Last updated
2022-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CFS, Emergency Department, Frailty, Frailty Syndrome, Geriatric Assessment

Brief summary

This prospective observational study will investigate the correlation of frailty in relation to serious outcomes. Serious outcomes are defined as: mortality within 30 days, admission to hospital, length of stay in the Emergency Department(ED), in hospital length of stay and revisits to the ED. The exposure, frailty, will be assessed according to Clinical Frailty Scale. ED patients \>65 years of age in a Swedish regional health care system (Region Östergötland, Sweden) comprising three EDs in Linköping, Norrköping and Motala. The outcomes will be compared according to the degree of frailty and censored over 7, 30 and 90 days respectively.

Detailed description

Frailty is a common clinical syndrome in older adults that carries an increased risk for poor health outcomes including falls, incident disability, hospitalization, and mortality. The clinical frailty scale (CFS) is a measure of frailty based on clinical judgement in a 9 level scale, categorized as vulnerable (1-4), mildly frail (5), moderatly frail (6) and severely and very severely frail (7-8).. A validation study of the CFS in community-dwelling older people showed that it performed better than measures of cognition, function or comorbidity in assessing risk for death. In a prospective observational study including consecutive ED patients aged 65 years or older The Hosmer-Lemeshow test indicated a good agreement between predicted probability and observed frequency of 30-day mortality and ICU admission. The aim of this study will be to investigate if the fraily, assessed according to CFS, is associated with increased 30-day mortality. in a Swedish Emergency Care context. Secondary outcomes included 7-and 90-day mortality, ED length of stay, hospital admission, hospital length of stay, subsequent falls and medication changes. Additionally, we collect data on morbidity and comorbidities to assess the association with the level of frailty. Since this is a multicenter study, possible geographic differences will be studied as well. Based on the results of this study, possible interventions could be identified to improve the care of the frail geriatric patients presenting at the ED.

Interventions

None listed

Sponsors

University Hospital, Linkoeping
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥65 years, able to answer any questions, alternatively have a proxy

Exclusion criteria

\- Patients: \<65 years

Design outcomes

Primary

MeasureTime frameDescription
Mortality in 30 daysAll cause mortality up to 90 days from index visitInvestigate level of mortality in cohort at 30 days

Secondary

MeasureTime frameDescription
Mortality in 7 and 90 daysAll cause mortality up to 90 days from index visitInvestigate level of mortality in cohort at 7 and 90 days
Admission to hospitalHospital admission on index visit, censored at 90 daysInvestigate level of all cause admissions in cohort
ED length of stayLength of stay at ED, censored at 4 daysInvestigate length of stay at ED
Hospital length of stayHospital length of stay from index visit, censored at 90 daysInvestigate hospital length of stay
Fall prevalence after the index visitFalls that resulted in further ED visits after index visit, censored in 90 daysFalls that resulted in further ED visits
Alterations in medication during the visit (based on codes for Anatomical, Therapeutic, Chemical classification (ATC-code))Alterations in medications from index visit and during the follow-up period, censored at 90 daysAlterations in medication and during the follow-up period
Revisitis to the EDNumber of newly registered visits to the emergency department after index visit, censored at 90 daysNumber of newly registered visits to the emergency department after index visit

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026